Abstract
Mice infected with an adenovirus mutant in which the E3 region is deleted, including TNF-resistance genes, develop fatal liver pathology within 3-4 days after infection. At least 10-fold more wild-type virus was needed to cause comparable pathology. These results indicate that the E3 region is critically involved in modulating the pathogenesis of adenovirus infection and that TNF may play a role in liver damage. To explore the latter possibility, the course of disease was examined in infected mice lacking TNFR-I and/or TNFRII, TNF only, or both TNF and lymphotoxin-alpha. Only mice lacking both TNFRI and TNFRII were protected from the lethal affects of the mutant adenovirus. Mice deficient in TNF or TNF and lymphotoxin-alpha displayed the fatal pathology. This outcome is consistent with the existence of another related ligand that binds TNFRI/II to mediate liver damage during infection with this mutant.
MeSH terms
-
Adenoviridae Infections / immunology*
-
Adenoviridae Infections / pathology*
-
Adenoviridae Infections / virology
-
Adenoviruses, Human / genetics
-
Adenoviruses, Human / immunology
-
Animals
-
Antigens, CD / genetics
-
Antigens, CD / metabolism
-
Antigens, CD / physiology*
-
DNA, Viral / analysis
-
Female
-
Humans
-
Immunity, Innate
-
Liver / immunology*
-
Liver / pathology*
-
Liver / virology
-
Lymphotoxin-alpha / genetics
-
Lymphotoxin-alpha / physiology*
-
Mice
-
Mice, Inbred C3H
-
Mice, Inbred C57BL
-
Mice, Inbred CBA
-
Mice, Knockout
-
Polymerase Chain Reaction
-
Receptors, Tumor Necrosis Factor / genetics
-
Receptors, Tumor Necrosis Factor / metabolism
-
Receptors, Tumor Necrosis Factor / physiology*
-
Receptors, Tumor Necrosis Factor, Type I
-
Receptors, Tumor Necrosis Factor, Type II
-
Tumor Necrosis Factor-alpha / deficiency
-
Tumor Necrosis Factor-alpha / genetics
-
Tumor Necrosis Factor-alpha / physiology*
Substances
-
Antigens, CD
-
DNA, Viral
-
Lymphotoxin-alpha
-
Receptors, Tumor Necrosis Factor
-
Receptors, Tumor Necrosis Factor, Type I
-
Receptors, Tumor Necrosis Factor, Type II
-
Tumor Necrosis Factor-alpha